Table 1.
Assignment | Volunteer | Saline | CEF | LLO | Son Lm | Sec Lm |
---|---|---|---|---|---|---|
Placebo | #4 day 0 | 5 | 200 | 3 | 8 | 3 |
day 42 | 13 | 215 | 5 | 295* | 470* | |
#6 day 0 | 0 | 0 | 0 | 83 | 33 | |
day 42 | 10 | 33 | 58 | 43 | 60 | |
#8 day 0 | 5 | 15 | 3 | 58 | 390 | |
day 42 | 10 | 20 | 5 | 68 | 198 | |
Active | #1 day 0 | 20 | 140 | 10 | 283 | 148 |
day 42 | 3 | 108 | 8 | 473 | 128 | |
#2 day 0 | 13 | 530 | 35 | 175 | 83 | |
day 42 | 15 | 933 | 35 | 200 | 218* | |
#3 day 0 | 13 | 90 | 10 | 100 | 18 | |
day 42 | 8 | 30 | 13 | 955* | 828* | |
#5 day 0 | 8 | 1285 | 5 | 128 | 110 | |
day 42 | 3 | 1013 | 50 | 433* | 260* | |
#7 day 0 | 8 | 628 | 5 | 13 | 38 | |
*day 49 | 13 | 645 | 5 | 778* | 1548* |
The asterisks denote a significant increase as defined in methods.